cbdMD, Inc. (YCBD-PA)

USD 0.68

(1.49%)

Revenue Summary of cbdMD, Inc.

cbdMD, Inc.'s latest annual revenue in 2023 was 24.15 Million USD , down -31.77% from previous year.
cbdMD, Inc.'s latest quarterly revenue in 2024 Q3 was 5.17 Million USD , up 18.22% from previous quarter.
cbdMD, Inc. reported a annual revenue of 35.4 Million USD in annual revenue 2022, down -20.41% from previous year.
cbdMD, Inc. reported a annual revenue of 44.48 Million USD in annual revenue 2021, up 6.2% from previous year.
cbdMD, Inc. reported a quarterly revenue of 4.37 Million USD for 2024 Q2, down -18.58% from previous quarter.
cbdMD, Inc. reported a quarterly revenue of 5.17 Million USD for 2024 Q3, up 18.22% from previous quarter.

Annual Revenue Chart of cbdMD, Inc. (2023 - 2016)

Historical Annual Revenue of cbdMD, Inc. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	24.15 Million USD	-31.77%
2022	35.4 Million USD	-20.41%
2021	44.48 Million USD	6.2%
2020	41.88 Million USD	77.09%
2019	23.65 Million USD	180.89%
2018	8.42 Million USD	88.16%
2017	4.47 Million USD	120.27%
2016	2.03 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	5.37 Million USD	-5.87%
2024 Q2	4.37 Million USD	-18.58%
2024 Q3	5.17 Million USD	18.22%
2023 Q4	5.71 Million USD	-6.68%
2023 Q3	6.11 Million USD	-1.93%
2023 FY	24.15 Million USD	-31.77%
2023 Q1	6.08 Million USD	-22.58%
2023 Q2	6.24 Million USD	2.54%
2022 Q2	9.62 Million USD	3.29%
2022 Q4	7.85 Million USD	-8.53%
2022 FY	35.4 Million USD	-20.41%
2022 Q1	9.32 Million USD	-4.81%
2022 Q3	8.59 Million USD	-10.76%
2021 Q1	12.32 Million USD	5.37%
2021 Q2	11.79 Million USD	-4.3%
2021 FY	44.48 Million USD	6.2%
2021 Q4	9.79 Million USD	-7.26%
2021 Q3	10.56 Million USD	-10.49%
2020 Q2	9.39 Million USD	-7.38%
2020 Q1	10.14 Million USD	16.85%
2020 FY	41.88 Million USD	77.09%
2020 Q4	11.69 Million USD	10.0%
2020 Q3	10.63 Million USD	13.17%
2019 Q1	1.24 Million USD	-14.04%
2019 FY	23.65 Million USD	180.89%
2019 Q4	8.68 Million USD	7.96%
2019 Q3	8.04 Million USD	41.79%
2019 Q2	5.67 Million USD	354.22%
2018 Q1	687.75 Thousand USD	-36.29%
2018 Q2	3.08 Million USD	347.97%
2018 Q3	3.19 Million USD	3.81%
2018 Q4	1.45 Million USD	-54.57%
2018 FY	8.42 Million USD	88.16%
2017 FY	4.47 Million USD	120.27%
2017 Q1	199.83 Thousand USD	-13.19%
2017 Q2	1.4 Million USD	604.84%
2017 Q3	1.78 Million USD	26.87%
2017 Q4	1.07 Million USD	-39.59%
2016 Q3	385.48 Thousand USD	0.0%
2016 Q4	230.2 Thousand USD	-40.28%
2016 FY	2.03 Million USD	0.0%

Peer Revenue Comparison of cbdMD, Inc.

Name	Revenue	Revenue Difference
China Pharma Holdings, Inc.	7.01 Million USD	-244.52%
cbdMD, Inc.	24.15 Million USD	0.0%
Zomedica Corp.	25.18 Million USD	4.092%